" Wang et al. 1 Clean version MS ID ARS-2016-6875.R3 Original Research Communication Age-dependent Allergic Asthma Development and Cystathionine gamma-Lyase Deficiency 1 Peipei Wang, 2,3 Lingyun Wu, 4 Yongjun Ju, 3 Ming Fu, 1,6 Tian Shuang, 5 Zhongming Qian*, 1,6 Rui Wang* 1 Department of Biology, Lakehead University, Thunder Bay, Ontario, Canada P7B7E1 2 Health Sciences North Research Institute, Sudbury, Ontario, Canada P3E 5J1 3 School of Human Kinetics, Laurentian University, Sudbury, Ontario, Canada P3E2C6 4 School of Kinesiology, Lakehead University, Thunder Bay, Ontario, Canada P7B7E1 5 Laboratory of Neuropharmacology, Fudan University School of Pharmacy, Shanghai, China. 6 Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Ontario, Canada P3E2C6 Running Head: H2S and age-dependent development of asthma * All correspondences should be addressed to: Dr. Zhongming Qian, Laboratory of Neuropharmacology, Fudan University School of Pharmacy, Shanghai, China. Email: qianzhongming@fudan.edu.cn Dr. Rui Wang, Laurentian University, 935 Ramsey Lake Road, Sudbury, Ontario, Canada P3E2C6. Tel: (705) 675-1151, ext. 3944. Fax: 705-671-3850. Email: rui.wang@laurentian.ca Footnote: Peipei Wang’s current address is Department of Pulmonary, Critical Care Medicine, Peking University People's Hospital, Beijing, China. Word count text (excluding references and figure legends): 5061 Reference number: 50 Number of greyscale illustrations: 6 Number of color illustrations: 3 (online 3) Key words: Asthma, gasotransmitter, H2S, S-sulfhydration, type-2 immune response Antioxidants and Redox Signaling © Mary Ann Liebert, Inc. DOI: 10.1089/ars.2016.6875 Page 1 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 2 2 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Abstract Aims: The pathogenic mechanisms for the higher prevalence of allergic asthma in children than in adults have not been settled. The aim of the present study is to examine whether the agedependent development of allergic asthma is caused by age-dependent expression of cystathionine gamma-lyase (CSE), a key enzyme that catalyzes the production of H2S. Results: Allergic asthma was induced with ovalbumin in wild-type (WT) and CSE knock-out (KO) mice at young and old ages. CSE expression and H2S production were lower in immune cells of young WT mice than those of old WT mice. Coincidently, more severe asthmatic symptoms with greater type-2 immunoreaction were found in young WT mice than old WT mice. H2S supplementation reversed the asthmatic symptoms. Lower expression levels of CSE proteins were also found in human umbilical cord blood mononuclear cells in comparison with that of peripheral blood mononuclear cells from adult people. The age-dependent asthma propensity vanished in CSE-KO mice but these mice developed more severe asthma than WT mice. More splenocytes were differentiated to type-2 cytokine-generating cells in young WT mice and in CSE-KO mice at all ages. This differentiation was inhibited by H2S donors. GATA3 translocation to the nucleus and type-2 immunoreaction of splenocytes were inhibited after GATA3 was S-sulfhydrated by H2S. Innovation and conclusion: This study for the first time demonstrated that lower abundance of CSE expression and H2S production enhances type-2 immunoreaction and renders a higher incidence of allergic asthma at a young age. As such, H2S level may be a biomarker for asthma development and a H2S-based strategy can be perceived for asthma prevention and treatment. Page 2 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 3 3 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Introduction Over 50% of all asthma cases attribute to atopy (2). The first 1-3 years of human life are critical for the development of atopic (allergic) asthma (16,34). Immune maturation of atopic children lags behind non-atopic children, with a persistent type-2-biased immune response to allergens (32). On the other hand, asthma development was much less severe if he early childhood was spent on a farm (9). One theory speculates that this phenomenon is related to the maturation of the developing neonate immune system stimulated by early gut microbial colonization. For example, the development of allergic asthma was more prominent in germ-free animals than in animals with normal microbial flora (24). The linkage between microbiota colonization in the gut and asthma development, however, has been unknown. Animals and humans at the neonatal stage have low density and phylogenetic diversity of their gut microbiota (8,17). Successive colonization of microbiota occurs in an age-dependent manner from weeks to years (13, 17). Gut microbiota can produce significant amount of H2S (40). Thus, low H2S production from microbiota in the gut during early childhood is expected. If this low level of exogenous H2S cannot be compensated by H2S produced by mammalian cells, the weakened anti-asthmatic effects of H2S would result in early and more severe asthma attack. Butyrate and pyridoxal 5′-phosphate, produced by bacteria, up-regulate H2S-generating enzymes, including cystathionine gamma-lyase (CSE), in mammalian cells (5, 19). CSE activities in brain, heart, aorta, liver, kidney, colon, cecum, and small intestine were higher in non-germ-free mice than in age-matched germ-free mice (33). In mouse liver tissues, the expression and activity of were very low after birth but at the age of 3 weeks the upregulation of CSE expression and activity reached the maximal levels (15). It appears that the age-dependent CSE/H2S development bears a correlation with the age-dependent asthma development. Page 3 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 4 4 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. The activity of CSE/H2S system has been implicated in asthma development. Adult asthma patients had lower plasma levels of H2S but more severe asthma symptoms (43). Animal models of allergic asthma, rats or mice, also had lower H2S levels in plasma and lung tissues than in age-matched healthy animals (7, 47). NaHS decreased the severity of ovalbumin (OVA)induced asthma, including the elevated type-2 cytokines in bronchoalveolar lavage fluid. The preceding studies led us to hypothesize that endogenous activity of CSE/H2S system in early life controls regulatess the type-2-biased immune response and that the low activities of CSE/H2S system in childhood instigates the higher incidence of asthma. Page 4 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 5 5 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Results Correlation of age and CSE levels with allergic asthma development OVA was used to induce allergic asthma at the dosages normalized by the respective body weights of young (3-4 weeks) and old mice (7-8 months). OVA-treatments of young WT mice have significantly increased lung resistance and decreased lung dynamic compliance (Cdyn) in response to aerosolized methacholine (MCh) (Fig. 1A).Airway responsiveness was much weaker in OVA-treated old WT mice, only about 50% of lung resistance increase and Cdyn decrease of those in OVA-treated young WT mice (Fig. 1A). OVA-induced inflammatory cell influx in bronchoalveolar lavage fluid (BALF), especially eosinophils, from young WT mice was approximately 3 times of that in old WT mice (Fig. 1B). BALF from young WT mice also had significantly higher level of interleukin-4 (IL-4) than that from old WT mice (Fig. 1C). These results are consistent with a clinical observation that enhanced lymphocyte cytokine responses were associated with the early onset of atopy (37). More peribronchial and perivascular inflammatory infiltrates were found in lung tissues of young than in those of old WT mice (Fig. 1D). Airway responsiveness to MCh challenge in non-asthmatic WT mice was also agedependent. The airway resistance of young WT mice was more than three times of that of old WT mice. On the other hand, the airway resistance did not show difference between young and old CSE-KO mice although it was significantly greater than that of old WT mice (Fig. 1E). It should noticed that without OVA sensitization and challenges WT and KO mice at different ages did not develop asthma and airway inflammation (Fig. 1F). In each of H&E-stained mouse lung slides, we counted 7 different bronchi to calculate total eosinophils. Each group of slides composed of 3-4 mice. There were 65±3 peribronchial Page 5 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 6 6 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. eosinophils per bronchus in OVA-treated WT-young mice whereas only 10±5 in OVA-treated WT-old mice (P<0.05). OVA-treated young and old CSE-KO mice had 114±12 and 107±4 peribronchial eosinophils per bronchus, respectively (P<0.05 vs. OVA-treated young and old WT-mice). MCh challenges of OVA-treated young CSE-KO mice caused similar airway resistance increase and Cdyn decrease as those of OVA-treated old CSE-KO mice (Fig. 1A). Inflammatory infiltrates in airways and type-2 cytokine levels (IL-4, IL-5 and IL-13) in BALF were comparable between OVA-treated young and old CSE-KO mice (Fig. 1B-D). CSE-KO mice exhibited greater airway hyper-responsiveness and more severe inflammation than age-matched WT mice (Fig. 1A-D). In addition to immunologically challenging the mice with body-weight normalized dosages as described in Materials and Methods (Fig. 1A and B), we also treated young and old mice using fixed amounts of OVA (40 μg for sensitization and 100 μg for challenge). With this alternative OVA treatment regime, young WT mice also developed higher airway responsiveness and more inflammatory infiltrates than old WT mice (Fig. 2). Correlation of CSE expression and type-2 cytokine production in allergic asthma development Mouse mediastinal lymph cells and splenocytes were isolated 5 days after OVAsensitization. These cells were re-stimulated with OVA for 3 days. In comparison with those from young WT mice, the cells from old WT mice produced lesser type-2 cytokines (IL-4, IL-5 and IL-13) after OVA re-stimulation (Fig. 3A and B). The levels of type-2 cytokines were similar between young and old CSE-KO mice (Fig. 3A and B). The cells from WT mice generated lesser type-2 cytokines than those from age-matched CSE-KO mice. CSE protein levels in splenocytes Page 6 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 7 7 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. from young WT mice were lower than those in splenocytes from old WT mice (Fig. 3C). The protein levels of mercaptopyruvate sulfurtransferase (MST) in splenocytes were similar between young and old WT mice. Cystathionine β-synthase (CBS) proteins were undetectable in splenocytes of young and old WT mice (Fig. 3D). Thus, lower expression of CSE proteins in splenocytes from young WT mice resulted in lesser H2S production in these cells than in the splenocytes from old WT mice (Fig. 3E). CBS or MST proteins were not detectable, but CSE proteins were spotted, in human spleen tissue (Fig. 3F). Human umbilical cord blood mononuclear cells (CBMCs) expressed lesser CSE proteins than peripheral blood mononuclear cells (PBMCs) from adult humans (38-55 years old) (Fig. 3G). While CBS proteins were clearly detected in mouse liver tissues (positive control), they were not detectable in PBMCs or CBMCs. Low abundance of MST proteins was detected in PBMCs. We also tested the therapeutic effect of NaHS at two doses, 14 and 39 μmole/kg (i.p.). NaHS at 39 μmole/kg (i.p., once a day) weakened airway hyper-responsiveness of OVAsensitized CSE-KO mice to 55.2±14.5% (n=5, p<0.05) and limited airway inflammatory infiltrates. The relative total cell numbers in BALF from CSE-KO mice was reduced to 74.9±10.5%, taking the average numbers of total cells in BALF from OVA-sensitized CSE-KO mice without NaHS treatment as 100% (n=5). Instead of giving higher concentrations of NaHS, we decided in the present study to use NaHS at low concentration (14 μmole/kg, i.p.) but increased the frequency of NaHS administration to twice a day. This new treatment regime was composed of two days NaHS treatment before OVA sensitization, and continued NaHS treatment during and two days after sensitization. OVA re-stimulation-induced IL-4, IL-5 and IL-13 production was significantly decreased by NaHS treatments, with IL-4 being decreased Page 7 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 8 8 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. most dramatically, in lymph cells and splenocytes from both young WT mice and CSE-KO mice (Fig. 3H and I). NaHS slightly decreased IL-4 level in splenocytes, but not in lymph cells, from old WT mice. NaHS increased IL-5 but decreased IL-13 production in splenocytes, and itdecreased both IL-5 and IL-13 production in lymph cells from old WT mice (Fig. 3H and I). These results indicate that the effect of CSE deficiency on type-2 immunitywas mediated by H2S, and that the inhibitory effect of NaHS, as a H2S donor, on type-2 immune response was greater in the absence of endogenous H2S. Furthermore, OVA-induced airway hyper-responsiveness to MCh as alleviated significantly by NaHS treatments by about 2 times in young/old CSE-KO mice and 1.6 times in young WT mice in comparison with saline treatments (Fig. 4A). OVA-challenged young WT mice and young/old CSE-KO mice also had lesser airway inflammatory cell infiltration, fewer peribronchial and perivascular inflammatory infiltrates in the lung, and lower levels of IL-4 and IL-5 in BALF after NaHS treatments in comparison with saline treatment control (Fig. 4B-D). NaHS treatment of old WT mice did not significantly change their airway responsiveness and inflammatory infiltration (Fig. 4A-D). These data suggest that NaHS treatment during sensitization phase protects against ensuing allergic asthma development when the expression of CSE and endogenous H2S level are suppressed. Differentiation of naïve immune cells and its inhibition by H2S in vitro Cultured splenocytes were differentiated into type-2 cytokine-generating cells under specific culture conditions. Splenocytes from old WT mice secreted much lesser type-2 cytokines than those from young WT mice (Fig. 5A). In consistence with in vivo OVAsensitization results (Fig. 3A and B), CSE-KO mouse splenocytes did not show such an age Page 8 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 9 9 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. related difference in their type-2 cytokine-generating abilities when polarized in vitro (Fig. 5A). Splenocytes from CSE-KO mice generated more IL-4, IL-5 and IL-13 than those from WT mouse (Fig. 5A). The inhibitory effect of NaHS treatments on type-2 cytokine production in splenocytes from CSE-KO mice was concentration-dependent (Fig. 5B). Signal transducer and activator of transcription factor-6 (STAT6) regulates naïve T cell differentiation and type-2 cytokine production (28). It can be activated by IL-4 and IL-13 (12). We found that IL-4 induced phosphorylation of STAT6 to the same degree in WT and CSE-KO mice (Fig. 5C). In IL-4-treated splenocytes from young CSE-KO mice, NaHS treatments did not alter STAT6 phosphorylation (Fig. 5D). GATA-3 is a transcription factor that binds to the DNA sequence \"GATA\". It participates in the regulation of innate and adaptive type-2 immune response (14). GATA3 distribution between nuclear and cytosolic fractions was investigated. The successful separation of nuclear from cytosolic fractions was confirmed by the lack of β-actin and presence of lambin b1 in the nuclear fraction, and the presence of β-actin and lack of lambin b1 in the cytosolic fraction (Fig. 5E and F; Fig. S1). In differentiated splenocytes from young WT mice, nuclear GATA3 protein levels were much higher than in those from old WT mice. In contrast, the levels of nuclear GATA3 proteins were similar in differentiated splenocytes from young and old CSEKO mice (Fig. 5E). NaHS treatments during differential culture decreased concentrationdependently the expression of nuclear GATA3 in splenocytes from young CSE-KO mice (Fig. 5F). In the experiments described in Fig. 5B, D, and F, only CSE-KO splenocytes were used in order to study NaHS effect in the absence of endogenous H2S. GATA3 S-sulfhydration induced by H2S Page 9 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 10 10 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. S-sulfhydration is a post-translational modification mechanism in which cysteine-SH groups are converted to –SSH (27). The levels of S-sulfhydrated GATA3 proteins were significantly higher in old WT mouse spleens than in those from young WT mice, and these levels in WT mouse spleens were much higher than in the spleens from young/old CSE-KO mice (Fig. 6A). GATA3 S-sulfhydration in HEK-293 cells, in which CSE was heterologously overexpressed, was substantially increased by NaHS and decreased by dl-propargylglycine (PPG) (Fig. 6B). S-sulfhydration of GATA3 proteins was suppressed by double mutation of cyteine84/182 (GATA3-C84/182) or cysteine-84/248 (GATA3-C84/248) (Fig. 6C). Decreased GATA3 nuclear translocation was suggested by the higher ratio of nucleus/cytosol GATA3 with mutated GATA3 than with wild-type GATA3 (Fig. 6D). Deficiency in type-1 immune response also contributes to atopy and asthma development (21). The effect of CSE expression on type-1 immune response was examined in vitro using cultured splenocytes. Under the culture conditions favoring T cell differentiation into type-1 cytokine-generating cells, splenocytes from old WT mice generated more interferon gamma (IFN-γ), a type-1 cytokine, than those from young WT mice (Fig. 7A). Splenocytes from CSEKO mice produced lesser IFN-γ than those from WT mice (Fig. 7A). NaHS did not have effect on IFN-γ production except at the high concentration of 30 μM (Fig. 7B). Both STAT4 and Tbox protein (T-bet) are essential for the initiation and maintenance of type-1 immune response (36). The IL-12-induced STAT4 phosphorylation was not affected by H2S (Fig. 7C and D). Lower nuclear level of T-bet was found in differentiated splenocytes from young/old CSE-KO mice as well as young WT mice (Fig. 7E). NaHS treatment (30 μM), on the other hand, increased nuclear T-bet level (Fig. 7F). It was reported previously that the inhibition of CSEwith PPG decreased the levels of T-bet, IL-12 and IFN-γ, delaying heart allograft rejection (39). Page 10 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 11 11 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Age-dependent defects in CSE/H2S signaling in the lung and airway tissues CSE protein was detected in both human and mouse lungs (Fig. 8A, B). Following the same patterns as seen in mouse splenocytes and human blood mononuclear cells (Fig. 3), CSE expression in lungs was low in 4-week WT mice, increased at the age of 8-week, and reached the highest level at 16 weeks of age (Fig. 8B). Thereafter, CSE protein levels in WT mouse lungs remained at the same age as in 16-week mice. In mouse airway tissues, CSE protein levels followed the same age-dependent patterns as seen in lungs from age-matched WT mice (Fig. 8C). CBS and MST proteins were also detected in airway tissues from WT mice. However, their expression levels did not alter as the mice became aged (Fig. 8C). Furthermore, H2S production was lowest in WT mouse lung and bronchial tissues at the age of 4 weeks. At the age of 8 and 16 weeks, H2S production reached the highest levels in WT mouse bronchi and lungs, respectively (Fig. S2). Page 11 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 12 12 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Discussion Early childhood is accompanied by immune immaturity, which favors type-2 dominant reactivity and renders children higher susceptibility of developing allergic asthma (1, 3). Low expression of CSE may explain this prevalence of childhood asthma attack. Our study found that young WT mice have lower expression CSE in their immune cells than in their counterparts of old mice. OVA-sensitization of young WT mice resulted in more type-2 immune responses and more severe allergic asthma symptoms than OVA-sensitized old WT mice. On the other hand, cse gene knock-out enhanced type-2 immune response and worsened asthma development independent of animal ages. The aforementioned outcomes of cse gene knock-out can be ascribed to the decreased endogenous H2S level. H2S at nanomolar concentrations potentiated T lymphocyte activation in vitro (25). H2S also up-regulated G protein-coupled receptor kinase 2 and CD11b in neutrophils (35). Our current study showed that NaHS alleviated OVAsensitization-induced type-2 response in peripheral lymph tissues in vivo. NaHS limited the differentiation of splenocytes, in vitro, into type-2 cytokine-producing cells. The frequency and concentrations of in vivo NaHS administrations in the current study were selected according to literature and our previous studies. H2S concentrations in mammalian tissues range from 30 to 100 μmole/kg (22). NaHS (14 μmole/kg, i.p.) was used in the present study due to its effectiveness and physiological relevance. Numerous previous studies have used this NaHS concentration for in vivo animal treatment (7, 47, 48). Type-2 cytokine genes are clustered on mouse chromosome 11 or human chromosome 5 (20). Our study shows that CSE/H2S-induced inhibition of type-2 immune response is not mediated by STAT6 (10). Instead, H2S inhibited asthma development by S-sulfhydrating GATA3 to decrease its nuclear translocation (Fig. 9). GATA3 is considered a master regulator in Page 12 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 13 13 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. type-2 response. It directly binds to Il-5 and Il-13 promoters. By acting on type-2 cytokine locus, GATA 3 regulates chromatin modification. GATA3-deficient CD4 + T cells cannot differentiate into T helper 2 (TH2) cells (49). Mouse and human GATA3 contain 12 conserved cysteine residues. Eight of them are located in the zinc finger region, limited their likelihood to be modulated. Among the remaining 4 cysteines, H2S S-sulfhydrates C84, C182, and C248. C248 locates at the very beginning of nuclear localization sequence (NLS) of GATA3. S-sulfhydration of C84, C182 and C248 may alter the structure of GATA3 and decrease its binding to nuclear import protein importin-a (23,46). Once C-84/182 or C-84/248 were double mutated, GATA3 S-sulfhydration level was decreased its nuclear expression increased. The proposed mechanisms for CSE/H2S mediated age-dependent asthma development are summarized in Fig. 9. The immature immune system in childhood is also marked with weak protective type-1 immune response (21). Previous studies showed that IFN-γ levels and atopy were inversely associated (31). Type-1 cytokines and T-bet suppress the expressions of type-2 cytokine and GATA3 genes. We found that higher CSE expression and endogenous H2S levels in old WT mice facilitated the differentiation of type-1 cytokine-generating cells by increasing nuclear Tbet expression. Exogenous NaHS also facilitated IFN-γ production albeit not as strong as its inhibitory effect on type-2 cytokine generation. Airway is the end target of asthma attack. Airway hyper-responsiveness in childhood increases the prevalence of childhood asthma (4, 38). Airway contraction and ventilation are determined by the contractility and proliferation of airway smooth muscle cells (ASMCs) as well as an array of inflammatory mediators secreted from these cells (50). In the present study, we confirmed the age-dependent expression pattern of CSE in WT mouse lungs as well as in WT Page 13 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 14 14 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. mouse airways. While CSE and CBS are both involved in the reverse-transsulfuration pathways, the former cleaves cystathionine and the latter generates cystathionine, and both generate H2S from L-cysteine cleavage. On the other hand, the production of H2S by MST requires the formation of the immediate substrate 3-mercaptopyruvate from L-cysteine (42). Neither CBS nor MST proteins showed an age-dependent expression profile in the involved organs in our study, suggesting that the age-dependent asthma development in our study does not bear a causative relationship with the CBS or MST. We showed previously the expression of CSE in vascular smooth muscle cells of mouse lung and ASMCs (7, 41). We show here that MCh-induced airway responsiveness was much higher in young WT mice and young/old CSE-KO mice than that of old WT mice (Fig. 1E). The mechanisms underlying H2S-induced relaxation of ASMCs including the opening of KATP channel (11) or inhibition of Ca 2+ release through inositol-1,4,5trisphosphate receptors (6). Low abundance of CSE in young mice results in decreased endogenous H2S level, leading to the development of airway hyper-responsiveness. H2S may also directly inhibit the release of pro-inflammatory mediators, such as IL-8, from ASMCs (29). In old WT mice, CSE/H2S system in ASMCs is matured and fully developed, which can offer protection against local inflammation and ASMC constriction during allergen exposures. We have previously reported the therapeutic effects of NaHS treatments during the OVA-challenge phase (7, 47), consistent to the local effects of H2S in the lung observed in the present study. In summary, endogenous H2S production in peripheral lymph tissues and the lung and exogenous H2S supplementation inhibit allergic asthma development by suppressing allergeninduced type-2 immune response and airway hyper-responsiveness. Lack of endogenous H2S production due to lower CSE expression in the early stage of development may underlie higher Page 14 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 15 15 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. incidence of childhood allergic asthma. Our findings may help the development of H2S-based, in addition to NO-based or anti-oxidant based (26, 30), prevention and treatment strategies for pediatric asthma. Page 15 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 16 16 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Innovation The development of allergic asthma is more often and more severe in childhood. The mechanisms for this higher prevalence of childhood asthma than in adulthood remain elusive. The present study for the first time demonstrates that deficiency of CSE/H2S pathway is responsible for the higher prevalence of allergic asthma development at young ages due to the lack of H2S-induced S-sulfhydration of GATA3 protein and the suppression of type-2 immune response. H2S supplementation at young ages may be considered as a novel protective tactic against allergic asthma. Page 16 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 17 17 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Materials and Methods H2S production measurements H2S generated by mouse lung tissues was measured as described previously (44). Briefly, the isolated mouse lung tissues were homogenized with 50 mM ice-cold potassium phosphate buffer (pH 6.8). The tissue homogenates were incubated with L-cysteine (10 mM, Sigma, St. Louis, MO) for 90 min at 37°C, and then trichloroacetic acid (Sigma) was added to stop the reaction. The level of methylene blue generated by the interaction of H2S with N,N-dimethyl-pphenylenediamine sulfate (Sigma) was determined with a FLUOstar OPTIMA microplate spectrophotometer (BMG LABTECH, Germany) at 670 nm. For measuring H2S generated by splenocytes (18), splenocytes were cultured in 50 ml cell culture flasks, the top of which were pre-coated with 5 ml zinc-agar. After 72 h culture, the agar layers were dissolved in 2 ml of N, N-dimethyl-p-phenylenediamine chloride (40 mM N, Ndpd in 7.2 M HCl). Iron chloride reagent (400 μl, 30 mM FeCl3 in 1.2 M HCl) was then added. Absorbance was measured at 670 nm using Synergy 2 Multi-Mode Reader (BioTek, USA). H2S concentration was calculated against a standard curve that was generated with NaHS at concentrations from 5 to 250 μM. H2S production from mouse bronchus tissues was measured and semi-quantitated using a modified lead sulfur method. Mouse bronchial tissues of 50 mg were homogenized in PBS buffer supplemented with 10 mM cysteine and 2 mM pyridoxal 5’-phosphate (PLP). A lead acetate H2S detection strips (Sigma, Aldrich, USA) was placed above the liquid phase in a closed container (covered 96-well plate) and incubated about 3 hours at 37˚C until lead sulfide darkening of the paper occurred. Then the reacted H2S detection strips were scanned with a CanoScan LiDE 700F scanner. The optical densities in arbitrary units of the reacted H2S strips from the scanned images Page 17 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 18 18 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. were analyzed and quantitated using imageJ software (1.47V, NIH, USA) and the data were plotted for different age groups. Allergic asthma model CSE gene knockout mice were generated in our lab on C57BL/6J×129SvEv background as previously described (44). Young (3-4 weeks old) and old (7-8 months old) WT and agematched CSE-KO mice were sensitized with OVA (2 μg per gram body weight i.p., Grade V, Sigma-Aldrich) in 100 μl aluminum hydroxide gel solution on days 0 and 7. Isofluraneanesthitzed mice were challenged with OVA (5 μg/gram body weight) in 30-40 μl phosphate buffered saline (PBS) by intratracheal inhalation on day 21 to day 23. NaHS treatments of selected groups of mice were conducted (14 μmole/kg i.p. twice a day) two days prior to sensitization until two days after sensitization (day minus-2 through day 2 and day 5 through day 9). All animal experiments were conducted in compliance with guidelines of Canadian Council on Animal Care and approved by the Animal Care Committee of Lakehead University, Ontario, Canada. Measurement of lung function To test airway resistance in response to increasing concentrations of aerosolized methacholine (1.5, 3.1, 6.2, 12.5 mg/ml), an R&C (resistance and compliance) system (Buxco, USA) was used. Data collection and process were accomplished with a FinePointe Software (Buxco, USA). Collection of bronchoalveolar lavage fluid (BALF) and examination of lung histology Page 18 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 19 19 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. To obtain BALF, mouse lungs were flushed three times with 0.8 ml PBS/1% BSA. Total cell numbers were counted using a hemocytometer. BALF cells were cytospined and stained with Wright–Giemsa staining solution for cell differential counting. The supernatants of BALF were then stored in -80°C for determining cytokine levels with ELISA (R&D, USA). The fixation of the left lobes of lungs was taken in 5 ml of 10% buffered formalin and the fixed tissues embedded in paraffin. The lung sections at 4 μm were stained with H&E reagents. Splenocytes and lymph cells isolation Mediastinal lymph nodes and spleens were mashed through a 40 μm cell strainer to obtain splenocytes and lymph node cells. Red Cell Lysis Buffer was used to remove erythrocytes from spleens. Cells were washed with PBS and RPMI 1640 medium before use. Type-2 cytokine-generating cell differentiation culture Splenocytes (200 μl, 1 million/ml) were seeded in 96-well plates and cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, 500 U penicillinstreptomycin and 50 μM β-mercaptoethanol. Mouse IL-4 (20 ng/ml, Peprotech, Canada), mouse IL-2 (20 ng/ml, Peprotech, Canada), anti-mouse IFN-γ (5 μg/mL, R4-6A2; eBioscience, USA), anti-mouse CD3ε (5 μg/ml, plate-bound, 145-2C11; eBioscience), anti-mouse CD28 (2 μg/ml, clone 37.51; eBioscience) were included in the culture medium,. In the experiments described in Fig. 5B, D and F, the culture medium contained NaHS at different concentrations. On day 3, the cells were passaged and cultured for an additional 3 days in 24-well plates containing IL-2 (20 ng/ml), IL-4 (20 ng/ml) with or without the addition of NaHS at different concentrations. Following the differentiation culture, splenocytes were re-stimulated with PMA/ionomycin Page 19 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 20 20 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. (1:1000, eBioscience) for 24 hours. ytokine levels in the culture medium were assayed with ELISA (R&D). Western blot Whole cell lysates of mouse splenocytes, human peripheral blood mononuclear cells (PBMC), and human cord blood mononuclear cells (CBMC) were prepared using RIPA lysis buffer (Thermo Scientific, USA) supplemented with Protease Inhibitor Cocktail (Sigma-Aldrich, USA). Human spleen and lung samples were purchased from Cure line (USA). PBMCs and CBMCs were purchase from Precision Bioservices (USA) and PromoCell (Germany). Immunoblotting was performed using mouse anti-CBS (1:1000, Abnova, Taiwan), rabbit antiCSE (1:1000, Proteintech, USA), rabbit anti-MST (1:500, Sigma-Aldrich, USA), rabbit antiphospho-STAT6, rabbit anti-STAT6 and mouse anti-GATA3 antibody (1:200, Santa Cruz Biotechnology, USA). To detect nucleus GATA3 expression, nuclear extracts were prepared with NE-PER Nuclear and Cytoplasmic Extraction Reagent (Pierce, Thermo Scientific, USA) following the manufacturer’s instructions. S-sulfhydration detection Modified biotin switch assay was performed as described previously (27). HEK 293 cells and spleen tissues were sonicated in HEN buffer (250 mM Hepes-NaOH (pH 7.7), 1 mM EDTA, and 0.1 mM neocuproine) containing 100 μM deferoxamine. After centrifuge, supernatant was blocked with HEN buffer containing 2.5% SDS and 20 mM methyl methanethiosulfonate (MMTS). The proteins were precipitated at -20°C and re-suspended in HEN buffer containing 1% Page 20 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 21 21 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. SDS. The samples were further incubated for 3 hours at 25 o C with biotin-HPDP (N-[6(biotinamido)hexyl]3’-(2’-pyridyldithio) propionamide) in dimethyl sulfoxide added. Biotinylated proteins were precipitated by streptavidin-agarose beads and eluted by SDS-PAGE sample buffer. Thereafter, Western blotting analysis was conducted using anti-GATA3 antibody (1:200, Santa Cruz Biotechnology). Eosinophils counting H&E stained lung sections were assessed under light microscope with x640 magnification. Seven bronchi were chosen randomly in each lung slide. Eosinophils surrounding each bronchus were counted and the average number of eosinophils per bronchus was calculated. Type-1 cytokine generating-cell differentiation culture Splenocytes (200 μl, 1 million/ml) were cultured in 96-well plates with RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, 500U penicillin-streptomycin and 50 μM β-mercaptoethanol. Mouse IL-12 (20 ng/ml, Peprotech), mouse IL-2 (20 ng/ml, R&D), anti-mouse IL-4 (5 μg/ml, 11B11, eBioscience), anti-mouse CD3ε (5 μg/ml, plate-bound, 145-2C11; eBioscience), and anti-mouse CD28 (2 μg/ml, clone 37.51; eBioscience), were included in the culture medium. NaHS at different concentrations was added to the culture medium in selective groups of experiments. On day 3, the cells were passaged and cultured for additional 3 days in 24-well plates containing IL-2 (20 ng/ml), IL-12 (20 ng/ml) with or without NaHS at different concentrations. Following the type-1 immune cell differentiation culture, splenocytes were re-stimulated with PMA/ionomycin (1:1000; eBioscience) for 72 hours. IFN-γ level in the culture medium was assayed with ELISA (eBioscience). Page 21 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 22 22 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. OVA re-stimulation in vitro Splenocytes and mediastinal lymph nodes were collected 5 days after OVA sensitization from 6 mice for each group. These were re-stimulated with OVA (100 μg/ml) for 72 h. The levels of IL-4, IL-5, and IL-13 in the supernatant were assayed with ELISA. Mutagenesis of GATA3 Single mutation at cyteine-84 (GATA3-C84), cysteine-182 (GATA3-C182), cyteine-248 (GATA3-C248), cysteine-375 (GATA3-C375) and double mutation at cyteine-84/182 (GATA3C84/182) or cysteine-84/248 (GATA3-C84/248) were conducted using the Quick Change SiteDirected Mutagenesis kit (Stratagene, USA) (45). DNA sequencing was performed to confirm the correctness of the mutants at the MOBIX lab of McMaster University, ON, Canada. pFAGGATA3 was purchased from Addgene (MA, USA). Statistical analyses The comparisons among WT-young, WT-old, KO-young, and KO-old mice were made using two-way ANOVA. The comparisons between control and NaHS treatment groups were made using unpaired t tests. One-way ANOVA followed by Dunnett post test were used for comparisons among different NaHS treatment conditions. Mann Whitney test was used when variance was different among groups or data were not normally distributed. P < 0.05 is considered statistically significant. All data are expressed as mean ± SEM. Data analysis and graph preparation were performed using GraphPad Prism Software version 5.0. Page 22 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 23 23 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Acknowledgement: This study was supported by research grants from American Asthma Foundation and Canadian Institutes of Health Research to RW. LW has been supported by a Mid-Career Investigator Award from the Heart and Stroke Foundation of Ontario, Canada. Meghan Marks helped with the artistic designing of Fig. 9 and Dr. Wendy Huang advised on the statistical analysis of the data. The technical support by Dr. Qiuhui Cao is also acknowledged. Author Disclosure Statement The authors have declared no conflict of interest. Page 23 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 24 24 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. List of Abbreviations ASMCs = airway smooth muscle cells BALF = bronchoalveolar lavage fluid CBMCs = cord blood mononuclear cells CBS = cystathionine β-synthase CLIC4 = chloride intracellular channel protein 4 CSE = cystathionine γ-lyase Cdyn = lung dynamic compliance H2S = hydrogen sulfide IFN-γ = interferon gamma Interleukin = IL KO = knock out MCh = methacholine MMTS = methyl methanethiosulfonate MST = mercaptopyruvate sulfurtransferase NaHS = sodium hydrosulfide NLS = nuclear localization sequence OVA = ovalbumin PBMCs = Peripheral blood mononuclear cells PBS = phosphate buffered saline PPG = dl-propargylglycine SSH = S-sulfhydration Page 24 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 25 25 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. STAT6= Signal transducer and activator of transcription factor-6 T-bet = T-box protein T helper 2 cells = TH2 cells WT = wild type Page 25 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 26 26 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. References [1] Adkins B, Leclerc C, and Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 4(7):55, 2004. [2] Arbes SJ Jr, Gergen PJ, Vaughn B, and Zeldin DC. Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2007; 120: 1139-1145, 2007. [3] Arshad SH, Tariq SM, Matthews S, and Hakim E. Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study. Pediatrics 108(2):E33.3-564, 2001. [4] Bisgaard H, Jensen SM, and Bønnelykke K. Interaction between asthma and lung function growth in early life. Am J Respir Crit Care Med 185(11):1183-1189, 2012. [5] Cao Q, Zhang L, Yang G, Xu C, and Wang R. Butyrate-stimulated H2S production in colon cancer cells. Antioxid Redox Signal 12(9):1101-1109, 2010. [6] Castro-Piedras I, and Perez-Zoghbi JF. Hydrogen sulphide inhibits Ca 2+ release through InsP3 receptors and relaxes airway smooth muscle. J Physiol 591(Pt 23):5999-6015, 2013. [7] Chen YH, Wu R, Geng B, Qi YF, Wang PP, Yao WZ, and Tang CS. Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma. Cytokine 45(2):117-123, 2009. [8] Del Chierico F, Petrucca A, Mortera SL, Vernocchi P, Rosado MM, Pieroni L, Carsetti R, Urbani A, and Putignani L. A metaproteomic pipeline to identify newborn mouse gut phylotypes. J Proteomics 97:17-26, 2014. [9] Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson WO, Braun-Fahrländer C, Page 26 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 27 27 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Heederik D, Piarroux R, and von Mutius E. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 364(8):701-709, 2011. [10] Elo LL, Järvenpää H, Tuomela S, Raghav S, Ahlfors H, Laurila K, Gupta B, Lund RJ, Tahvanainen J, Hawkins RD, Oresic M, Lähdesmäki H, Rasool O, Rao KV, Aittokallio T, and Lahesmaa R. Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming. Immunity 32(6):852-862, 2010. [11] Fitzgerald R, DeSantiago B, Lee DY, Yang G, Kim JY, Foster DB, Chan-Li Y, Horton MR, Panettieri RA, Wang R, and An SS. H2S relaxes isolated human airway smooth muscle cells via the sarcolemmal K(ATP) channel. Biochem Biophys Res Commun 446(1):393-398, 2014. [12] Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111(4):677-690; quiz 691, 2003. [13] Hirayama K, Miyaji K, Kawamura S, Itoh K, Takahashi E, and Mitsuoka T. Development of intestinal flora of human-flora-associated (HFA) mice in the intestine of their offspring. Exp Anim 44(3):219-222, 1995. [14] Hoyler T, Klose CS, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins EL, Voehringer D, Busslinger M, and Diefenbach A. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37(4):634-648, 2012. [15] Ishii IN, Akahoshi N, Yu XN, Kobayashi Y, Namekata K, Komaki G, and Kimura H. Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem J. 381(Pt 1):113-123, 2004. [16] Jackson DJ, Hartert TV, Martinez FD, Weiss ST, and Fahy JV. Asthma: NHLBI Page 27 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 28 28 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc 11 Suppl 3: S139-145, 2014. [17] Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C, Björkstén B, Engstrand L, and Andersson AF. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 63(4):559-566, 2014. [18] Kartha RV, Zhou J, Hovde LB, Cheung BW, and Schröder H. Enhanced detection of hydrogen sulfide generated in cell culture using an agar trap method. Anal Biochem 423(1):102-108, 2012. [19] Kau AL, Ahern PP, Griffin NW, Goodman AL, and Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature 474(7351):327-336, 2011. [20] Koh BH, Hwang SS, Kim JY, Lee W, Kang MJ, Lee CG, Park JW, Flavell RA, and Lee GR. Th2 LCR is essential for regulation of Th2 cytokine genes and for pathogenesis of allergic asthma. Proc Natl Acad Sci USA 107(23):10614-10619, 2010. [21] Lambert L, Sagfors AM, Openshaw PJ, and Culley FJ. Immunity to RSV in Early-Life. Front Immunol 5:466, 2014. [22] Levitt MD, Abdel-Rehim MS, and Furne J. Free and acid-labile hydrogen sulfide concentrations in mouse tissues: anomalously high free hydrogen sulfide in aortic tissue. Antioxid Redox Signal 15(2):373-378, 2011. [23] Malik M, Shukla A, Amin P, Niedelman W, Lee J, Jividen K, Phang JM, Ding J, Suh KS, Curmi PM, and Yuspa SH. S-nitrosylation regulates nuclear translocation of chloride intracellular channel protein CLIC4. J Biol Chem 285(31):23818-23828, 2010. [24] Mazmanian SK, Liu CH, Tzianabos AO, and Kasper DL. An immunomodulatory Page 28 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 29 29 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1):107-118, 2005. [25] Miller TW, Wang EA, Gould S, Stein EV, Kaur S, Lim L, Amarnath S, Fowler DH, and Roberts DD. Hydrogen sulfide is an endogenous potentiator of T cell activation. J Biol Chem 287(6):4211-4221, 2012. [26] Montuschi P, and Barnes PJ. New perspectives in pharmacological treatment of mild persistent asthma. Drug Discov Today 16(23-24):1084-91, 2011. [27] Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, and Snyder SH. H2S signals through protein S-sulfhydration. Sci Signal 2(96):ra72, 2009. [28] Oh CK, Geba GP, and Molfino N. Investigational therapeutics targeting the IL-4/IL13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev 19(115):46-54, 2010. [29] Perry MM, Hui CK, Whiteman M, Wood ME, Adcock I, Kirkham P, Michaeloudes C, and Chung KF. Hydrogen sulfide inhibits proliferation and release of IL-8 from human airway smooth muscle cells. Am J Respir Cell Mol Biol 45(4):746-752, 2011. [30] Profita M, Montuschi P, Bonanno A, Riccobono L, Montalbano AM, Ciabattoni G, Albano GD, Liotta G, Bousquet J, Gjomarkaj M, and La Grutta S. Novel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases. Int J Immunopathol Pharmacol 23(4):1211-9, 2010. [31] Rothers J, Halonen M, Stern DA, Lohman IC, Mobley S, Spangenberg A, Anderson D, and Wright AL. Adaptive cytokine production in early life differentially predicts total IgE levels and asthma through age 5 years. J Allergy Clin Immunol 128(2):397-402.e392, 2011. Page 29 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 30 30 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. [32] Rowe J, Kusel M, Holt BJ, Suriyaarachchi D, Serralha M, Hollams E, Yerkovich ST, Subrata LS, Ladyman C, Sadowska A, Gillett J, Fisher E, Loh R, Soderstrom L, Ahlstedt S, Sly PD, and Holt PG. Prenatal versus postnatal sensitization to environmental allergens in a high-risk birth cohort. J Allergy Clin Immunol 119: 1164-1173, 2007. [33] Shen X, Carlström M, Borniquel S, Jädert C, Kevil CG, and Lundberg JO. Microbial regulation of host hydrogen sulfide bioavailability and metabolism. Free Radic Biol Med 60:195-200, 2013. [34] Sly PD, Boner AL, Björksten B, Bush A, Custovic A, Eigenmann PA, Gern JE, Gerritsen J, Hamelmann E, Helms PJ, Lemanske RF, Martinez F, Pedersen S, Renz H, Sampson H, von Mutius E, Wahn U, and Holt PG. Early identification of atopy in the prediction of persistent asthma in children. Lancet 372: 1100-1106, 2008. [35] Spiller F, Orrico MI, Nascimento DC, Czaikoski PG, Souto FO, Alves-Filho JC, Freitas A, Carlos D, Montenegro MF, Neto AF, Ferreira SH, Rossi MA, Hothersall JS, Assreuy J, and Cunha FQ. Hydrogen sulfide improves neutrophil migration and survival in sepsis via KATP channel activation. Am J Respir Crit Care Med 182(3):360-368, 2010. [36] Thieu VT, Yu Q, Chang HC, Yeh N, Nguyen ET, Sehra S, and Kaplan MH. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 29(5):679-690, 2008. [37] Turner SW, Heaton T, Rowe J, Suriyaarachchi D, Serralha M, Holt BJ, Franklin PJ, Stick SM, Goldblatt J, Sly PD, le Souëf PN, and Holt PG. Early-onset atopy is associated with enhanced lymphocyte cytokine responses in 11-year-old children. Clin Exp Allergy 37(3):371-380, 2007. [38] Turner SW, Young S, Goldblatt J, Landau LI, and Le Souëf PN. Childhood asthma and Page 30 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 31 31 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. increased airway responsiveness: a relationship that begins in infancy. Am J Respir Crit Care Med 179(2):98-104, 2009. [39] Vuillefroy de Silly R, Coulon F, Poirier N, Jovanovic V, Brouard S, Ferchaud-Roucher V, Blancho G, and Vanhove B. Transplant tolerance is associated with reduced expression of cystathionine-γ-lyase that controls IL-12 production by dendritic cells and TH-1 immune responses. Blood 119(11):2633-2643., 2012. [40] Wallace JL, and Wang R. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat Rev Drug Discov 14(5):329-345, 2015. [41] Wang P, Zhang G, Wondimu T, Ross B, and Wang R. Hydrogen sulfide and asthma. Exp Physiol 96(9):847-852, 2011. [42] Wang R. Physiological implications of hydrogen sulfide – A whiff exploration that blossomed. Physiol Rev 92(2):791-896, 2012. [43] Wu R, Yao WZ, Chen YH, Geng B, and Tang CS. [Plasma level of endogenous hydrogen sulfide in patients with acute asthma]. Beijing Da Xue Xue Bao 40(5):505-508, 2008. [44] Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, and Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322(5901):587-590, 2008. [45] Yang G, Zhao K, Ju Y, Mani S, Cao Q, Puukila S, Khaper N, Wu L, and Wang R. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal 18(15):1906-1919, 2013. [46] Yang Z, Gu L, Romeo PH, Bories D, Motohashi H, Yamamoto M, and Engel JD. Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are Page 31 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 32 32 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. organized into distinct structural domains. Mol Cell Biol 14(3):2201-2212, 1994. [47] Zhang G, Wang P, Yang G, Cao Q, and Wang R. The inhibitory role of hydrogen sulfide in airway hyperresponsiveness and inflammation in a mouse model of asthma. Am J Pathol 182(4):1188-1195, 2013. [48] Zhao W, Zhang J, Lu Y, and Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20(21):6008-6016, 2001. [49] Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, Wang Q, Killeen N, Urban JF Jr, Guo L, and Paul WE. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol 5(11):1157-1165, 2004. [50] Zuyderduyn S, Sukkar MB, Fust A, Dhaliwal S, and Burgess JK. Treating asthma means treating airway smooth muscle cells. Eur Respir J 32(2):265-274, 2008. Page 32 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 33 33 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Figure Legend. Page 33 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 34 34 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 34 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 35 35 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 1. CSE deficiency increased the severity of asthma in OVA-induced mouse allergic asthma model. (A) Mouse airway responsiveness measured as airway resistance and Cdyn. WT-y: WT young mice; WT-o: WT old mice; KO-y: CSE-KO young mice; KO-o: CSE-KO old mice. (B) Total cell numbers, macrophages (Mac), eosinophils (Eos), neutrophils (Neut) and lymphocytes (Lymph) in BALF. (C) Cytokine levels in BALF. (D) Representative H&E-stained mouse lung sections. Scale bars, 200 μm. Arrows point to peribronchial and perivascular inflammation. The results in each group were generated from 10-15 animals. Data are expressed as mean ± SEM. Statistical significance was determined with two-way analysis of variance (ANOVA). For A, B, & C, * P<0.05 for WT-young mice compared with WT-old mice; # P<0.05 for CSE-KO mice compared with young or old WT mice. (E) Airway responsiveness was measured as airway Page 35 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 36 36 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. resistance and Cydn. * P<0.05 when compared with WT old group. (F) Representative H&Estained mouse lung sections. Scale bars, 200 μm. WT-y: WT young mice; WT-o: WT old mice; KO-y: CSE-KO young mice; KO-o: CSE-KO old mice. (To see this illustration in color the reader is referred to the web version of this article at www.liebertonline.com/ars) Page 36 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 37 37 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 37 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 38 38 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 2. CSE deficiency increased the severity of asthma in mouse allergic asthma model induced with equal amount of OVA treatments. (A) Mouse airway responsiveness measured as airway resistance and Cdyn. WT-y: WT young mice; WT-o: WT old mice; KO-y: CSE-KO young mice; KO-o: CSE-KO old mice. (B) Total cell numbers, macrophages (Mac), eosinophils (Eos), neutrophils (Neut) and lymphocytes (Lymph) in BALF. The results in each group were generated from 8-10 animals. Data are expressed as mean ± SEM. Statistical significance was determined with two-way ANOVA. * P<0.05 for WT-young mice compared with WT-old mice; # P<0.05 for CSE-KO mice compared with young and old WT mice. Page 38 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 39 39 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 39 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 40 40 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 3. CSE/H2S suppressed OVA sensitization-induced differentiation of mediastinal lymph cells and splenocytes. (A-B) Cytokine levels in the culture media of mediastinal lymph cells (A) and splenocytes (B), as assessed by ELISA (n=6). (C) CSE protein levels in splenocytes (n=4). (D) CBS and MST protein levels in splenocytes. (E) H2S generated by cultured splenocytes (n=4). (F) CBS, CSE and MST protein levels in human cord blood mononuclear cells (CBMC), Page 40 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 41 41 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. human peripheral blood mononuclear cells (PBMC), and human spleen sample. (G) Expression levels of CSE proteins in CBMC (n=5) and PBMC (n=6). (H-I) Relative cytokine levels in the culture media of mouse mediastinal lymph cells (H) and mouse splenocytes (I). Mean cytokine levels of respective control groups are set as 100% (n=6). Data are expressed as mean ± SEM. Statistical significance was determined with two-way ANOVA (comparisons among WT-young, WT-old, KO-young and KO-old groups) and unpaired t tests (comparisons between control and NaHS treatment groups). *P<0.05 for WT-young mice compared with WT-old mice in (A, B, C, and E), PBMC compared with CBMC in (G), and NaHS treatment group compared with control group in (H and I); #P<0.05 for CSE-KO mice compared with WT mice at the same age. The full unedited western blot images, corresponding to each and all gel images in this figure, can be found in supplemental Fig. 3S. Page 41 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 42 42 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 42 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 43 43 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 43 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 44 44 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 4. NaHS treatment significantly improved OVA-induced allergic asthma symptoms in WT young mice and CSE-KO mice. (A) Relative airway resistance and Cdyn of mice with and without NaHS treatment. Mean resistance or mean Cdyn values of respective control groups are set as 100%. (B) Relative total cell numbers, macrophages (Mac), eosinophils (Eos), neutrophils (Neut), and lymphocytes (Lymph) in BALF. The average numbers of total cells, macrophages, eosionophils, neutrophils and lymphocytes in BALF from respective control groups are set as 100%. (C) Relative cytokine levels in BALF. Mean cytokine levels of respective control groups are set as 100%. (D) Representative H&E-stained lung sections of Page 44 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 45 45 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. NaHS-treated mice. Scale bars, 200 μm. The results in each group were collected from 6 animals. Data are expressed as mean ± SEM. Statistical significance was determined with unpaired t-test. *P <0.05 for NaHS treatment group compared with control group. (To see this illustration in color the reader is referred to the web version of this article at www.liebertonline.com/ars) Page 45 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 46 46 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 46 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 47 47 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 5. Endogenous and exogenous H2S reduced the differentiation of splenocytes into type-2 cytokine-generating cells in vitro. (A-B) IL-4, IL-5 and IL-13 levels in the culture medium of Page 47 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 48 48 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. splenocytes with or without NaHS pre-treatment. Mean cytokine levels of NaHS-0 μM groups in (B) are set as 100%. (C-D) IL-4-treatment-induced STAT6 phosphorylation in splenocytes with or without NaHS pre-treatment. (E-F) Nuclear and cytosolic GATA3 expression in differentiated splenocytes with or without NaHS pre-treatment. Only CSE-KO-young splenocytes were used in (B, D, and F) to minimize the potential interference of endogenous H2S on NaHS effects. n=4-6 in (A and B). Images in (C-F) represent 4 independent experiments. Statistical significance was determined with two-way ANOVA (comparisons among WT-young, WT-old, CSE-KO-young and CSE-KO-old groups) and one-way ANOVA followed by Dunnett post test (comparisons among different NaHS treatment conditions). *P<0.05 for WT-young group compared with WTold group or NaHS treatment groups compared with NaHS-0 μM group; # P<0.05 for CSE-KO group compared with WT group at the same age. The molecular weights of STAT6 and GATA3 are 110 kD and 50 kD, respectively. The full unedited western blot images, corresponding to each and all gel images in this figure, can be found in supplemental Fig. 4S. Page 48 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 49 49 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 49 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 50 50 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 6. S-sulfhydration of GATA3. (A) Endogenous S-sulfhydration of GATA3 in mouse spleens (n=4). (B) S-sulfhydration of GATA3 in HEK-293 cells (n=4). (C) S-sulfhydration of wild-type and mutated GATA3 in HEK-293 cells. In the mutants (C84/C182 or C84/C248), the targeted cysteines were replaced by serines. (D) Nuclear and cytosolic expressions of wild-type and mutated GATA3 in HEK-293 cells (n=4). Statistical significance was determined with two-way ANOVA (comparisons among WT-young, WT-old, CSE-KO-young and CSE-KO-old groups in A) and one-way ANOVA followed by Dunnett post test (comparisons among different groups in Page 50 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 51 51 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. B and D). *P<0.05 for WT-young mice compared with WT-old mice in (A), or NaHS (30 μM) and PPG (1 mM) compared with the control group in (B), and C84/182S and C84/248S mutants compared with wild-type GATA3 in (D). # P<0.05 for CSE-KO mice compared with WT mice at the same age in (A). The molecular weight of GATA3 is 50 kD. The full unedited western blot images, corresponding to each and all gel images in this figure, can be found in supplemental Fig. 5S. Page 51 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 52 52 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 52 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 53 53 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 7. Endogenous and exogenous H2S enhanced the differentiation of splenocytes into IFN-γgenerating cells in vitro. (A-B) IFN-γ levels in the culture media of splenocytes. Mean IFN-γ level of NaHS-0 μM group in (B) is set as 100%. (C-D) IL-12-treatment induced STAT4 phosphorylation in splenocytes. (E-F) Nuclear and cytosolic T-bet expression in splenocytes. Images in (C-F) represent 4 independent experiments. Statistical significance was determined with two-way ANOVA (comparisons among WT-young, WT-old, CSE-KO-young and CSEKO-old groups) and one-way ANOVA followed by Dunnett post test (comparisons among Page 53 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 54 54 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. different NaHS treatment conditions). *P<0.05 for WT-young compared with WT-old mice or NaHS-30 µM group compared with NaHS-0 µM group; # P<0.05 for CSE-KO mice compared with WT mice. The molecular weights of STAT4, Lambin b1, and T-bet are 89 kD, 66 kD, and 62 kD, respectively. The full unedited western blot images, corresponding to each and all gel images in this figure, can be found in supplemental Fig. 6S. Page 54 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 55 55 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 8. Age-dependent expression of CSE proteins in human and mouse lung tissues. A) The expression of different H2S-generating enzymes in human lung sample (purchased from Cure line, USA). B) CSE protein levels in the lungs from WT mice of different ages (n=4 for each group). *P<0.05 when compared with 4 weeks old WT mice. C) The protein levels of H2Sgenerating enzymes in the airways of WT mice at different ages. CBS, CSE, and MST protein Page 55 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 56 56 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. levels in the bronchial tree and trachea (n=4 for each group). * P<0.05 when compared with 4 weeks old WT mice. The full unedited western blot images, corresponding to each and all gel images in this figure, can be found in supplemental Fig. 7S. Page 56 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 57 57 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 57 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 58 58 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Fig. 9. Proposed mechanisms for the roles of CSE/H2S pathway in the age-dependent Page 58 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 59 59 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. development of allergic asthma. Eos: eosinophils, Mac: macrophages, Lym: lymphocytes. The greater severity of asthma in young WT mice (compared with old WT mice) can be explained by the age-dependent CSE/H2S expression pattern in splenocytes. Lower levels of CSE proteins and H2S in splenocytes from the young WT mice result in decreased S-sulfhydration of GATA3, increasing its nuclear translocation. This promotes the differentiation of splenocytes into type-2 cytokine-generating cells and the development of more severe asthma. (To see this illustration in color the reader is referred to the web version of this article at www.liebertonline.com/ars) Page 59 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 60 60 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. MS ID ARS-2016-6875 / 2 nd Revision Supplementary Information Age-dependent Allergic Asthma Development and Cystathionine gamma-Lyase Deficiency 1 Peipei Wang, 2,3 Lingyun Wu, 4 Yongjun Ju, 2 Ming Fu, 2 Tian Shuang, 5 Zhongming Qian*, 1,6 Rui Wang* 1 Department of Biology, Lakehead University, Thunder Bay, Ontario, Canada P7B7E1 2 Health Sciences North Research Institute, Sudbury, Ontario, Canada P3E 5J1 3 School of Human Kinetics, Laurentian University, Sudbury, Ontario, Canada P3E2C6 4 School of Kinesiology, Lakehead University, Thunder Bay, Ontario, Canada P7B7E1 5 Laboratory of Neuropharmacology, Fudan University School of Pharmacy, Shanghai, China. 6 Department of Biology, Laurentian University, Sudbury, Ontario, Canada P3E2C6 Running Head: H2S and age-dependent development of asthma * All correspondences should be addressed to: Dr. Zhongming Qian, Laboratory of Neuropharmacology, Fudan University School of Pharmacy, Shanghai, China. Email: qianzhongming@fudan.edu.cn Dr. Rui Wang, Laurentian University, 935 Ramsey Lake Road, Sudbury, Ontario, Canada P3E2C6. Tel: (705) 675-1151, ext. 3944. Fax: 705-671-3850. Email: rui.wang@laurentian.ca Page 60 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 61 61 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Supplementary Figure Legends Fig. S1. Confirmation of the separation of nuclear fraction from cytosolic fraction of mouse splenocytes. The β-actin and lambin B1 were applied as the cytosol and nuclear marker, respectively (2). Results are representative of three independent experiments with the same results. WT-y: WT young mice; WT-o: WT old mice; KO-y: CSE-KO young mice; KO-o: CSEKO old mice. Fig. S2. H2S generated by mouse lungs and bronchi. (A) H2S production by mouse lungs. n=3 measurements for each age group composed of 60-80 mice. (B) H2S production by mouse bronchi. n=3 measurement for each age group composed of 17-20 mice. Data are expressed as mean ± SEM. Statistical significance was determined with one-way ANOVA. *P<0.05, **P<0.01 when compared with 4 weeks old mice, # P<0.05 when compared with 8 weeks old mice. Fig. S3. The full unedited western blot images, corresponding to the gel images in Fig. 3. Fig. S4. The full unedited western blot images, corresponding to the gel images in Fig. 5. Fig. S5. The full unedited western blot images, corresponding to the gel images in Fig. 6. Fig. S6. The full unedited western blot images, corresponding to the gel images in Fig. 7. Fig. S7. The full unedited western blot images, corresponding to the gel images in Fig. 8. Page 61 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . 62 62 A n ti o x id an ts a n d R ed o x S ig n al in g A g ed ep en d en t A ll er g ic A st h m a D ev el o p m en t an d C y st at h io n in e g am m a -L y as e D ef ic ie n cy ( d o i: 1 0 .1 0 8 9 /a rs .2 0 1 6 .6 8 7 5 ) T h is p ap er h as b ee n p ee rre v ie w ed a n d a cc ep te d f o r p u b li ca ti o n , b u t h as y et t o u n d er g o c o p y ed it in g a n d p ro o f co rr ec ti o n . T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. Page 62 of 62 A nt io xi da nt s & R ed ox S ig na lin g A ge -d ep en de nt A lle rg ic A st hm a D ev el op m en t a nd C ys ta th io ni ne g am m aL ya se D ef ic ie nc y (d oi : 1 0. 10 89 /a rs .2 01 6. 68 75 ) T hi s ar tic le h as b ee n pe er -r ev ie w ed a nd a cc ep te d fo r pu bl ic at io n, b ut h as y et to u nd er go c op ye di tin g an d pr oo f co rr ec tio n. T he f in al p ub lis he d ve rs io n m ay d if fe r fr om th is p ro of . "
